A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.

Clinical trial NCT03553108 · COMPLETED

Trial details

NCT number: NCT03553108
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumor

Start date: 2018-05-16
Primary completion: 2019-03-12
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.